Аннотация
BackgroundPatients with metabolic syndrome are at a greater risk of experiencing a cerebrovascular event.Several studies show that patients with metabolic syndrome have asymptomatic ischemic brain injury.In this case, there is a need for rapid determination of asymptomatic brain lesions and prediction of acute stroke. AimsThe aim of the study was to determine the neuron-specific enolase (NSE) serum level in patients with metabolic syndrome and the value of this level for forecasting acute stroke. MethodsThe study used the following information to determine metabolic syndrome: waist circumference, total cholesterol, triglycerides, high-density lipoprotein cholesterol, blood pressure, and blood glucose.Doppler sonography mapping of the brachiocephalic trunk was held to determine the percentage of the carotid artery stenosis.To determine asymptomatic ischemic brain injury, the NSE serum marker was measured.Statistical processing of the measurements was performed using the H test and the Mann-Whitney test.The possible link between MS and NSE were determined by logistic regression analysis.Mathematical modeling was performed using logistic regression. ResultsThere are statistically significant differences in NSE concentrations in groups with metabolic syndrome and ischemic stroke patients.This assertion is confirmed by logistic regression analysis, which revealed the existence of a relationship between metabolic syndrome and increased concentration of NSE. ConclusionPatients with metabolic syndrome have an increased concentration of NSE.This indicates the presence of asymptomatic ischemic neuronal damage.A prognostic model for determining the probability that patients with metabolic syndrome will have an acute stroke was developed.